In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens

Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway

(2012) Timothy R. Sampson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

(2012) Michael Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens

(2012) Christopher P. Randall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

‘Old’ antibiotics for emerging multidrug-resistant bacteria

(2012) Phillip J. Bergen et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A call for action

(2012) Patrice Savard et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymyxins and their novel derivatives

(2010) Martti Vaara   CURRENT OPINION IN MICROBIOLOGY

Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin

(2010) M. Vaara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Colistin in the 21st century

(2009) Roger L Nation et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES